Mannatech Inc

Mannatech Inc

Mannatech Inc was founded in 1993 by Samuel L. Caster and a small group of investors in Coppell, Texas, as a direct-selling health-and-wellness firm. The company went public on the NASDAQ in 1999 (ticker: MTEX). Its core product line centers on Ambrotose, a glyconutrition supplement developed under a proprietary patent portfolio covering plant-derived polysaccharides. The firm's revenue model relies on a global network of hundreds of thousands of independent associates who sell products through in-home parties, online channels, and branded events. Segment mix includes dietary supplements (roughly 80% of revenue), weight-management products, and topical skin-care items. Mannatech manufactures its own products at a facility in Coppell and licenses technology in select markets including Australia, Canada, Japan, Taiwan, and South Africa. Revenue has declined from a peak of roughly $360 million in 2011 to approximately $110 million as of fiscal 2024 (per SEC filings). The company maintains no externally disclosed AUM. It operates without an independent investment office; capital allocation is managed by the CFO and board. In February 2024, Mannatech completed a corporate restructure that reduced its board from nine to five seats, and appointed Al Bala as President and CEO in April 2023 (per SEC filings). Mannatech is structurally distinct from a family office: it is a publicly traded corporation with a direct-selling sales force, not a vehicle for private family wealth. The company does run modest capital — cash and equivalents of roughly $8 million as of fiscal 2024 (per SEC filings) — but is not an allocator of outside capital or a multi-family office.